Tag: Washington DC
Navigating the GOP’s Healthcare Agenda: Balancing Health and Insurance
RFK Jr.'s Unconventional Stance on Health Insurance
In a surprising turn of events, Robert F. Kennedy Jr., known for his Make American Healthy Again movement, has been chosen by President Trump to lead the Department...
FDA Urges AI Device Manufacturers to Improve Testing and Performance Transparency
FDA Urges AI Device Manufacturers to Improve Testing and Performance TransparencyThe Food and Drug Administration (FDA) is calling for increased transparency from developers of medical devices that utilize artificial intelligence (AI) technology....
Jay Bhattacharya: Trump’s Choice to Lead NIH
President-elect Trump has made his selection for the role of leading the National Institutes of Health known, with Stanford University professor Jay Bhattacharya being chosen for the position, as announced by his transition team...
PhRMA Membership Dues Drop by Nearly $100 Million due to Major Drugmakers Exiting
PhRMA Membership Dues Plummet by $100 Million After Major Drugmakers ExitIn a significant blow to the Pharmaceutical Research and Manufacturers of America (PhRMA), three major pharmaceutical companies, AbbVie, AstraZeneca, and Teva, made the decision...
RFK Jr. as HHS Secretary: Scientists’ Opinions and Analysis
President-elect Donald Trump has chosen Robert F. Kennedy Jr. to lead the Department of Health and Human Services. This decision has sparked controversy, as RFK Jr. is known for being a vaccine skeptic. The...
Nominate Vaccine Skeptic RFK Jr. to Run HHS: Trump’s Controversial Decision
President-elect Trump has selected Robert F. Kennedy Jr., an environmental lawyer and vaccine skeptic, as his choice to lead the Department of Health and Human Services. Trump made the announcement on Truth Social, expressing...
Reaction to Trump’s selection of RFK Jr. for HHS leadership
Leaders in the biopharma world and scientific community were taken aback by the news that President-elect Donald Trump has chosen Robert F. Kennedy Jr. to lead the Department of Health and Human Services. This...
Patrizia Cavazzoni Departs FDA’s Drug Center: What it Means for the Agency
Patrizia Cavazzoni’s Departure and Its Implications for the FDAPatrizia Cavazzoni, the esteemed leader of the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER), has announced her departure from the agency on...
ACA Subsidy Boost and Antitrust Speech Impact: What You Need to Know
Good day, and thank you for allowing me to share some interesting insights with you. I'm still active on the platform previously known as Twitter, which shows that old habits die hard. It seems...
The Impact of Trump and Robert F. Kennedy Jr. on Vaccine Confidence and Safety:...
Donald Trump's recent win could lead to a significant impact on how vaccines are regulated and distributed in the United States due to the influence of longtime vaccine skeptic Robert F. Kennedy Jr. Kennedy...
Reining in AI Use in Medicare Advantage: Biden Administration’s Plan
The Biden administration recently announced a series of proposed changes to private Medicare plans aimed at improving coverage, regulating the use of artificial intelligence, and ensuring access to behavioral health providers and additional benefits....
Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount Program
Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount ProgramA recent warning from a U.S. government agency has put pharmaceutical giant Sanofi in hot water over its decision to alter payment terms...
